Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2857 of 5804
-
New light device aims to end guesswork in ear infection diagnosis
Diagnosis Recruiting nowOtitis media is more common in young children and it is estimated that 75% of all children experience at least one episode before the age of three. Otitis media is one of the common pediatric diagnoses and recurrent episodes account for the most commonly performed surgical proced…
Sponsor: University of California, Irvine • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
New therapy aims to ease the heavy burden on cancer caregivers
Symptom relief OngoingThe purpose of this study is to compare two types of therapy for caregivers of cancer patients: Emotion Regulation Therapy for Cancer Caregivers (ERT-C) and Cognitive Behavioral Therapy (CBT-C). The researchers want to see if ERT-C is better than, the same as, or worse than tradi…
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC
-
Personalized dosing may reduce transplant side effects in kids
Knowledge-focused Recruiting nowOne of the major challenges to improve the outcome of hematopoietic stem cell transplantation (HSCT) is the reduction of toxicity and non-relapse mortality caused by the pre-transplant conditioning regimen, while maintaining efficacy. Treosulfan (TREO) (L-treitol-1,4-bis-methanes…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can a higher dose of rituximab stop ITP relapses in kids?
Disease control Recruiting nowThe purpose of this study is to determine if a dose dense administration of Rituximab in newly diagnosed acute immune thrombocytopenic purpura (ITP) and determine relapse rate following this treatment. Correlative studies will be performed as outlined in the appendices. Quality…
Phase: PHASE1 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New drug combo shows promise for rare bone marrow cancer
Disease control OngoingThe purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of INCB057643 as monotherapy or combination with ruxolitinib for participants with myelofibrosis (MF) and other myeloid neoplasms.
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Does the pfizer vaccine work as well in immunosuppressed people? new study aims to find out
⭐️ VACCINE ⭐️ CompletedThe study is designed as an open, non-randomized, phase IV cohort study in which the mRNA vaccine Comirnaty will be given in two doses. Analyses will be performed on blood and saliva, investigating humoral and cellular vaccine responses. Occurence of local or systemic reactogenic…
Phase: PHASE4 • Sponsor: Karolinska University Hospital • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:01 UTC
-
Antioxidant drug shows promise for kids with NF1
Disease control CompletedChildren with neurofibromatosis type 1 (NF1) commonly suffer from the effects of cognitive, behavioral, and motor impairments. At present, there is no specific treatment for this NF1 complication. In this project, the investigators will assess the safety and clinical benefit of N…
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Shock to the system: new device helps stroke survivors walk better
Symptom relief CompletedThis interventional study evaluates the effects of an overground propulsion neuroprosthesis that delivers adaptive neurostimulation assistance to the paretic plantarflexors and dorsiflexors of people post-stroke. Individuals with chronic post-stroke hemiparesis will walk with and…
Phase: NA • Sponsor: Boston University Charles River Campus • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New disinfectant may slash heart device infections
Disease control OngoingUniversity of Schleswig-Holstein Campus Kiel is sponsoring the European TauroPace Registry. This investigator-initiated local, prospective, non-interventional, multi-center study includes patients undergoing cardiac implantable electronic placement including and not limited to pl…
Sponsor: University of Kiel • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug aims to cut steroid use in rare hormone disorder
Disease control TerminatedAn investigation of the ability of Tildacerfont to reduce supraphysiologic glucocorticoid dosing in classic Congenital adrenal hyperplasia (CAH) subjects up to 76 weeks of treatment. Optional open label extension up to 240 weeks.
Phase: PHASE2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
How many chiropractic visits work best for Veterans' back pain?
Symptom relief CompletedThis study evaluates how Veterans with chronic low back pain (cLBP) respond to varying doses of chiropractic therapy and how health services utilization are impacted as a result. There are 2 phases in this study. In Phase 1, half of participants will receive a low dose (1-5 visi…
Phase: NA • Sponsor: Palmer College of Chiropractic • Aim: Symptom relief
Last updated Jun 26, 2026 17:49 UTC
-
Can a texting bot keep lung cancer patients on track?
Disease control OngoingThe objective of this project is to identify effective strategies to help patients with lung cancer manage side effects and achieve optimal adherence to oral targeted therapies. To achieve this objective, we will evaluate the effect of a novel, bidirectional conversational agent,…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for kids with chronic upset stomach: drug trial shows promise
Symptom relief CompletedThe purpose of this study is to evaluate pharmacokinetics, efficacy and safety of Z-338 of pediatric patients with functional dyspepsia (FD). In Part 1, the pharmacokinetics and safety of single oral dose of Z-338 100 mg are evaluated. In Part 2, the efficacy and safety of Z-33…
Phase: PHASE3 • Sponsor: Zeria Pharmaceutical • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Could a poop transplant fix cancer treatment side effects?
Knowledge-focused Recruiting nowThis trial studies the role of the gut microbiome and effectiveness of a fecal transplant on medication-induced gastrointestinal (GI) complications in patients with melanoma or genitourinary cancer. The gut microbiome (the bacteria and microorganisms that live in the digestive sy…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Thyme honey mouth rinse shows promise for Radiation-Induced dry mouth
Symptom relief CompletedXerostomia is the most frequent complication among patients who receive radiotherapy (RT) . The prevalence of xerostomia has been reported to be from 73.5% to 93% (Kakoei S.,2012). Damage to normal tissues can result by radiotherapy as it is not selective to cancer cells, and so …
Phase: PHASE4 • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Bone-Saving drug may shield patients after bariatric surgery
Prevention CompletedIn a randomised placebo-controlled trial assess effects of zoledronic acid for prevention of bone and muscle loss after bariatric surgery.
Phase: PHASE2 • Sponsor: Stinus Gadegaard Hansen • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Digital ads take on vaping: can a scroll change a habit?
Prevention CompletedThere is little published data on exposure to and evaluations of large-scale, online tobacco control campaigns. This project addresses the gap. Under 2 specific aims, the investigators will identify the independent effects of varying levels of digital message exposure to promote …
Phase: NA • Sponsor: George Washington University • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
Triple-Drug cocktail shows promise in early prostate cancer trial
Disease control CompletedThe goal of this study is to determine the recommended phase 2 dose of the multi-drug combination of abiraterone, cabozantinib, and nivolumab in conjunction with ongoing androgen deprivation therapy in previously untreated metastatic hormone-sensitive prostate cancer patients. Th…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
12,000-Person study aims to unlock genetic secrets of rare diseases
Knowledge-focused Recruiting nowFor the retrospective data analysis, patients with genetic diseases of any age and, if available, other family members, for whom genetic analyzes were carried out between 10/2016 and 12/2020, should be included. This equates to approximately 13,000 records, minus combined analyze…
Sponsor: University Hospital Tuebingen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Can a watercress drink help flush out Cancer-Causing chemicals?
Disease control CompletedThe goal of this research is to determine if consuming one of two study drinks will help enhance the detoxification of multiple environmental toxicants and cancer causing agents, particularly in subjects who are null for glutathione-S-transferase M1 (GSTM1), glutathione-S-transfe…
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC